Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4MG3E | — |
she had administered only the liquid portion of Priorix; she had administered only the liquid portion of Priorix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 56-year-old male patient who received MMR (Priorix) (batch number 4MG3E, expiry date 01-DEC-2026) for prophylaxis. On 01-JUN-2025, the patient received the 1st dose of Priorix. On 01-JUN-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: she had administered only the liquid portion of Priorix) and inappropriate dose of vaccine administered (Verbatim: she had administered only the liquid portion of Priorix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-JUN-2025 A pharmacist reported that she had administered only the liquid portion of priorix to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The shot was administered on 1 June 2025 and corresponded to the first dose. She wanted to know how to proceed and how to get a new diluent portion for reconstituting the lyophilized part as usual.